Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1026
https://www.valueinhealthjournal.com/article/S1098-3015(17)31360-8/fulltext
Title :
Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31360-8&doi=10.1016/j.jval.2017.08.1026
First page :
A579
Section Title :
HEALTH CARE TREATMENT STUDIES
Open access? :
No
Section Order :
977